SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 93 filers reported holding SEELOS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $165,558 | -86.5% | 899,773 | -12.3% | 0.00% | -100.0% |
| Q2 2023 | $1,226,056 | +22.9% | 1,025,988 | -28.9% | 0.00% | +50.0% |
| Q1 2023 | $997,719 | +19.2% | 1,443,459 | +17.1% | 0.00% | 0.0% |
| Q4 2022 | $836,842 | -53.8% | 1,232,463 | -30.0% | 0.00% | -60.0% |
| Q3 2022 | $1,813,000 | +3.4% | 1,760,614 | -31.7% | 0.01% | +25.0% |
| Q2 2022 | $1,754,000 | -45.9% | 2,578,143 | -33.4% | 0.00% | +33.3% |
| Q1 2022 | $3,242,000 | +40.3% | 3,869,128 | +173.0% | 0.00% | -40.0% |
| Q4 2021 | $2,310,000 | -34.3% | 1,417,041 | -2.9% | 0.01% | -44.4% |
| Q3 2021 | $3,518,000 | -9.3% | 1,459,894 | -0.6% | 0.01% | -18.2% |
| Q2 2021 | $3,878,000 | -58.9% | 1,468,770 | -22.3% | 0.01% | -66.7% |
| Q1 2021 | $9,433,000 | – | 1,890,402 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENDELL JEFFREY L | 4,933,024 | $4,133,000 | 0.30% |
| ACUTA CAPITAL PARTNERS, LLC | 295,896 | $248,000 | 0.12% |
| Connacht Asset Management LP | 231,551 | $194,000 | 0.10% |
| Uniplan Investment Counsel, Inc. | 1,564,605 | $1,310,000 | 0.08% |
| AdvisorShares Investments LLC | 358,796 | $301,000 | 0.05% |
| 1492 Capital Management LLC | 99,819 | $84,000 | 0.04% |
| Woodline Partners LP | 2,803,230 | $2,349,000 | 0.04% |
| Ikarian Capital, LLC | 257,883 | $215,000 | 0.03% |
| Sovereign Financial Group, Inc. | 75,000 | $63,000 | 0.02% |
| Aquatic Capital Management LLC | 6,400 | $5,000 | 0.01% |